Category Science and Technology
Françoise Baylis continues to advocate for broad societal consensus on the future of germline genome editing and sees the Parliamentary Assembly of the Council of Europe as an ally given their support of broad public engagement.
Erika Dyck describes how the recent surge in psychedelic research presents opportunities to rethink how we do science, and how we measure the impact of science.
Françoise Baylis and Alana Cattapan defend the current prohibition in Canada on making genetic alterations that can be passed on to future generations.
Conrad Fernandez describes the ethical challenges related to the use of CAR T-cell therapy for cancer patients.
Dylan Roskams Edris describes risks associated with implantable remote bio-monitoring devices.
Françoise Baylis stresses that decisions about the modification of the human germline should not be made without broad societal consultation.
Jean-Christophe Bélisle-Pipon calls attention to issues of accessibility and transparency related to the collection and sale of physician prescribing data by data solution companies.